1,542 results found
Osborne Clarke | United Kingdom | 15 Dec 2022
The UK Patents Court puts an arrow through Teva's application for declaratory relief
The Court of Appeal has upheld the decision of the High Court to reject Teva's application for Arrow declaratory relief for importing and selling…
Bird & Bird LLP | Belgium, European Union, Netherlands | 9 Dec 2022
Rebranding generics as branded medicines - CJEU issues new guidance
The CJEU has provided welcome new guidance on when parallel importers can rebrand generic medicines with the original trade mark of the reference…
Venable LLP | USA | 5 Dec 2022
Win for Novartis on motion to dismiss in pharmaceutical patent litigation case
🕑 1 minute Novartis Pharmaceuticals Corporation recently secured a victory on a motion to dismiss certain defendants' counterclaims in patent litigation concerning Novartis's Entresto drug product. Judge Richard G Andrews, of the District Court for the District of Delaware, agreed with Novartis that a defendant who files a section viii statement does not face an article III controversy of......
McDermott Will & Emery | USA | 6 Oct 2022
Hold That Generic, Please: Supreme Court Grants Emergency Request to Stay Federal Circuit’s Mandate
In a rare action by the Supreme Court of the United States, Chief Justice Roberts granted Novartis’s emergency request for a stay of a mandate from…
De Berti Jacchia Franchini Forlani Studio Legale | European Union | 21 Jul 2022
La Corte di Giustizia mette la parola fine alla saga Avastin/Lucentis
In data 7 luglio 2022, la Corte di Giustizia dell’Unione Europea si è Pronunciata nella Causa C-261/21, F. Hoffmann-La Roche Ltd e a. Contro Autorità…
Kilpatrick Townsend & Stockton LLP | USA | 26 Jan 2022
The Sound of Silence: Claiming Negative Limitations
The specification shall contain a written description of the invention. To meet the written description requirement, the applicant must convey with…
Lexology PRO | USA | 14 Apr 2021
Imposing a monitor is “very fact-dependent”, says SEC official
A senior SEC enforcement official said it’s often a challenge for government lawyers to determine whether to impose a compliance monitor on a company.
Lexology PRO | Australia, Brazil, Canada, etc. | 9 Feb 2021
How compliance games boost business engagement
Rafael Ferri, legal director at Novartis (Brazil), looks back at his experiments with gamification to boost compliance-business engagement while working as head of legal and compliance at Sandoz, a division of Novartis Group.Interview conducted by Samantha Gilbert, content editor for Lexology PRO.
Lexology PRO | Australia, Brazil, Canada, etc. | 9 Feb 2021
How to increase business-compliance engagement
Rafael Ferri, legal director at Novartis (Brazil), discusses the best practices to boost compliance-business engagement that he used while working as head of legal and compliance at Sandoz, a division of Novartis Group.Interview conducted by Samantha Gilbert, content editor for Lexology PRO.
Lexology PRO | Australia, Brazil, Canada, etc. | 9 Feb 2021
How to facilitate business-compliance engagement during COVID-19
Rafael Ferri, legal director at Novartis (Brazil), discusses the best practices he used to boost compliance-business engagement during the COVID-19 pandemic in his role as head of legal and compliance at Sandoz, a division of Novartis Group.Interview conducted by Samantha Gilbert, content editor for Lexology PRO.
